Adult Normative Performance of the Quotient ADHD System
NCT01308450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2013-11-27
Summary
This study is being conducted to enhance and extend the clinical utility of the Quotient® ADHD System Adolescent and Adult Version Test by adding large numbers of well-screened controls to the existing Quotient® ADHD System database of adolescents and adults (ages 15-55).
Conditions
- ADHD
Sponsors & Collaborators
-
BioBehavioral Diagnostics Company
lead INDUSTRY
Eligibility
- Min Age
- 15 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- United States
Study Locations
More Related Trials
-
Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With ADHD
NCT02184598 ·Status: UNKNOWN ·Phase: NA
-
An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD
NCT07217977 ·Status: ENROLLING_BY_INVITATION
-
Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations
NCT00745524 ·Status: COMPLETED
-
An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations
NCT07220330 ·Status: ENROLLING_BY_INVITATION
-
Assessing Mobile Apps for Adult ADHD
NCT06256003 ·Status: COMPLETED ·Phase: NA
-
Concordance of the Quotient Attention Deficit Hyperactivity Disorder (ADHD) System Report With Teacher and Parent Assessments for Symptoms of ADHD
NCT01118650 ·Status: WITHDRAWN
-
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
NCT00000388 ·Status: COMPLETED ·Phase: PHASE4
-
Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants
NCT01310439 ·Status: COMPLETED
-
Screening Protocol for Adults With ADHD
NCT00592254 ·Status: UNKNOWN
-
Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)
NCT00181857 ·Status: COMPLETED
-
Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD
NCT00307268 ·Status: COMPLETED
-
A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00554385 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
NCT05683249 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adult Attention Deficit Hyperactivity Disorder
NCT01692782 ·Status: COMPLETED ·Phase: PHASE2
-
A Systematic Study of Assessment of Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT05588713 ·Status: UNKNOWN ·Phase: NA
-
Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00686933 ·Status: COMPLETED ·Phase: PHASE2
-
Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study
NCT06305078 ·Status: COMPLETED ·Phase: NA
-
A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00391729 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00683462 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
NCT00483106 ·Status: COMPLETED ·Phase: PHASE4
-
Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder
NCT01615679 ·Status: COMPLETED
-
Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.
NCT05631626 ·Status: COMPLETED ·Phase: PHASE3
-
Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00001206 ·Status: COMPLETED
-
Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents
NCT03213613 ·Status: COMPLETED ·Phase: NA
-
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
NCT05805176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA